Importance of monocarboxylate transporter 8 for the blood-brain barrier-dependent availability of 3,5,3' -triiodo-L-thyronine

Endocrinology

Volumn 150, Issue 5, 2009, Pages 2491-2496

  Ceballos, Ainhoa ^a   Belinchon, Monica M ^a   Sanchez Mendoza, Eduardo ^a   Grijota Martinez, Carmen ^b   Dumitrescu, Alexandra M ^c   Refetoff, Samuel ^c   Morte, Beatriz ^b,d   Bernal, Juan ^a,b,d  

^a CSIC   (Spain)

^b Center for Biomedical Research on Rare Diseases   (Spain)

^c UNIVERSITY OF CHICAGO   (United States)

^d INSTITUTO DE INVESTIGACIONES BIOMÉDICAS ALBERTO SOLS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; MONOCARBOXYLATE TRANSPORTER 8; THYROXINE; CARRIER PROTEIN; NEUROGRANIN; NRGN PROTEIN, MOUSE; SLC16A2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CELL MEMBRANE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG TRANSPORT; FEMALE; GENE EXPRESSION; GRANULAR CELL; HYPOTHYROIDISM; KNOCKOUT MOUSE; LOW DRUG DOSE; MALE; MOUSE; NERVE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TARGET CELL; WILD TYPE; ANIMAL; C57BL MOUSE; CELL CULTURE; GENETICS; METABOLISM; MOUSE MUTANT; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; CELLS, CULTURED; FEMALE; MALE; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROGRANIN; NEURONS; TRIIODOTHYRONINE;

EID: 66449128624     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1616     Document Type: Article

References (18)

1. Dumitrescu AM, Liao XH, Best TB, Brockmann K, Refetoff S 2004 A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. Am J Hum Genet 74:168-175
2. Friesema EC, Grueters A, Biebermann H, Krude H, von Moers A, Reeser M, Barrett TG, Mancilla EE, Svensson J, Kester MH, Kuiper GG, Balkassmi S, Uitterlinden AG, Koehrle J, Rodien P, Halestrap AP, Visser TJ 2004 Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet 364:1435-1437
3. Refetoff S, Dumitrescu AM 2007 Syndromes of reduced sensitivity to thyroid hormone: genetic defects in hormone receptors, cell transporters and deiodi- nation. Best Pract Res Clin Endocrinol Metab 21:277-305
4. Gruters A2007Thyroid hormone transporter defects. Endocr Dev 10:118-126
5. Visser WE, FriesemaEC, Jansen J, Visser TJ 2008 Thyroid hormone transport in and out of cells. Trends Endocrinol Metab 19:50 -56
6. Dumitrescu AM, Liao XH, Weiss RE, Millen K, Refetoff S 2006 Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (mct) 8-deficient mice. Endocrinology 147:4036-4043
7. Trajkovic M, Visser TJ, Mittag J, Horn S, Lukas J, Darras VM, Raivich G, Bauer K, Heuer H 2007 Abnormal thyroid hormone metabolism in mice lacking the monocarboxylate transporter 8. J Clin Invest 117:627-635
8. Heuer H, Maier MK, Iden S, Mittag J, Friesema EC, Visser TJ, Bauer K 2005 Themonocarboxylatetransporter8 linkedtohumanpsychomotorretardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology 146:1701-1706
9. Roberts LM, Woodford K, Zhou M, Black DS, Haggerty JE, Tate EH, Grindstaff KK, Mengesha W, Raman C, Zerangue N 2008 Expression of the thyroid hormone transporters MCT8 (SLC16A2) and OATP14 (SLCO1C1) at the blood- brain barrier. Endocrinology149:6251-6261
10. Sugiyama D, Kusuhara H, Taniguchi H, Ishikawa S, Nozaki Y, Aburatani H, Sugiyama Y 2003 Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood-brain barrier: high affinity transporter for thyroxine. JBiol Chem 278:43489-43495
11. Boado RJ, LiJY, Nagaya M, ZhangC, Pardridge WM1999 Selective expression of the large neutral amino acid transporter at the blood-brain barrier. Proc Natl Acad Sci USA 96:12079-12084
12. Bernal J, Guadano-Ferraz A 2002 Analysis of thyroid hormone-dependent genes in the brain by in situ hybridization. Methods Mol Biol 202:71-90
13. Guadano-Ferraz A, Escamez MJ, Rausell E, Bernal J 1999 Expression of type 2 iodothyronine deiodinase in hypothyroid rat brain indicates an important role of thyroid hormone in the development of specific primary sensory systems. JNeurosci 19:3430-3439
14. Manzano J, Morte B, Scanlan TS, Bernal J 2003 Differential effects of tri- iodothyronine and the thyroid hormone receptor beta-specific agonist GC-1 onthyroidhormonetargetgenesinthebrain. Endocrinology144:5480-5487
15. Guadano-Ferraz A, ObregoSn MJ, St. Germain DL, Bernal J 1997 The type 2 iodothyronine deiodinase is expressed primarily inglial cells in the neonatal rat brain. Proc Natl Acad Sci USA 94:10391-10396
16. Palha JA, Nissanov J, Fernandes R, Sousa JC, Bertrand L, Dratman MB, Morreale de Escobar G, Gottesman M, Saraiva MJ 2002 Thyroid hormone distribution in the mouse brain: the role of transthyretin. Neuroscience 113:837-847
17. Blay P, Nilsson C, Owman C, Aldred A, Schreiber G 1993 Transthyretin expression in the rat brain: effect of thyroid functional state and role in thy- roxine transport. Brain Res 632:114-120
18. Dratman MB, Crutchfield FL, Schoenhoff MB 1991 Transport of iodothyronines from bloodstream to brain: contributions byblood:brainandchoroid plexus:cerebrospinal fluid barriers. Brain Res 554:229-236